Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015.

2.

Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013.

Simbiri KO, Biddle J, Kinyera T, Were PA, Tenge C, Kawira E, Masalu N, Sumba PO, Lawler-Heavner J, Stefan CD, Buonaguro FM, Robinson D, Newton R, Harford J, Bhatia K, Mbulaiteye SM.

Infect Agent Cancer. 2014 Sep 11;9:32. doi: 10.1186/1750-9378-9-32. eCollection 2014.

3.

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens.

Buonaguro FM, Tornesello ML, Buonaguro L.

J Transl Med. 2015 Jan 27;13(1):33. doi: 10.1186/s12967-015-0400-9.

4.

Antigen-specific vaccines for cancer treatment.

Tagliamonte M, Petrizzo A, Tornesello ML, Buonaguro FM, Buonaguro L.

Hum Vaccin Immunother. 2014;10(11):3332-46. doi: 10.4161/21645515.2014.973317.

PMID:
25483639
5.

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.

Tornesello ML, Annunziata C, Buonaguro L, Losito S, Greggi S, Buonaguro FM.

J Transl Med. 2014 Sep 16;12:255. doi: 10.1186/s12967-014-0255-5.

6.

HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.

Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F.

Cancer Lett. 2014 Sep 1;351(2):198-205. doi: 10.1016/j.canlet.2014.06.003. Epub 2014 Jun 24. Review.

PMID:
24971935
7.

Cancer diagnostic and predictive biomarkers.

Buonaguro FM, Pauza D, Tornesello ML, Hainaut P, Franco R, Marincola FM.

Biomed Res Int. 2014;2014:980163. doi: 10.1155/2014/980163. Epub 2014 Apr 3. No abstract available.

8.

Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines.

Shoja Z, Tagliamonte M, Jalilvand S, Mollaei-Kandelous Y, De Stradis A, Tornesello ML, Buonaguro FM, Buonaguro L.

J Med Virol. 2015 Jan;87(1):102-11. doi: 10.1002/jmv.23973. Epub 2014 May 5.

PMID:
24797918
9.

Systems vaccinology for cancer vaccine development.

Petrizzo A, Tagliamonte M, Tornesello M, Buonaguro FM, Buonaguro L.

Expert Rev Vaccines. 2014 Jun;13(6):711-9. doi: 10.1586/14760584.2014.913484. Epub 2014 Apr 28. Review.

PMID:
24766452
10.

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.

De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, Berretta M, Gini A, Zucchetto A, Buonaguro FM, De Paoli P, Zignego AL.

Biomed Res Int. 2014;2014:710642. doi: 10.1155/2014/710642. Epub 2014 Feb 26.

11.

Aberrant glycosylation as biomarker for cancer: focus on CD43.

Tuccillo FM, de Laurentiis A, Palmieri C, Fiume G, Bonelli P, Borrelli A, Tassone P, Scala I, Buonaguro FM, Quinto I, Scala G.

Biomed Res Int. 2014;2014:742831. doi: 10.1155/2014/742831. Epub 2014 Feb 13.

12.

CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.

Bonelli P, Tuccillo FM, Borrelli A, Schiattarella A, Buonaguro FM.

Biomed Res Int. 2014;2014:361020. doi: 10.1155/2014/361020. Epub 2014 Jan 29. Review.

13.

Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Tornesello ML, Giorgi Rossi P, Buonaguro L, Buonaguro FM; HPV Prevalence Italian Working Group.

Front Oncol. 2014 Feb 20;4:31. doi: 10.3389/fonc.2014.00031. eCollection 2014.

14.

The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD.

Borrelli A, Schiattarella A, Bonelli P, Tuccillo FM, Buonaguro FM, Mancini A.

Biomed Res Int. 2014;2014:476789. doi: 10.1155/2014/476789. Epub 2014 Jan 6.

15.

Infectious Agents and Cancer reviewer acknowledgement 2013.

Buonaguro FM, Mbulaiteye SM.

Infect Agent Cancer. 2014 Jan 31;9(1):5. doi: 10.1186/1750-9378-9-5.

16.

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach.

Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

J Transl Med. 2014 Jan 15;12:11. doi: 10.1186/1479-5876-12-11.

17.

Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.

Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM.

Biomed Res Int. 2013;2013:519619. doi: 10.1155/2013/519619. Epub 2013 Dec 9. Review.

18.

Cancer-associated CD43 glycoforms as target of immunotherapy.

Tuccillo FM, Palmieri C, Fiume G, de Laurentiis A, Schiavone M, Falcone C, Iaccino E, Galandrini R, Capuano C, Santoni A, D'Armiento FP, Arra C, Barbieri A, Dal Piaz F, Venzon D, Bonelli P, Buonaguro FM, Scala I, Mallardo M, Quinto I, Scala G.

Mol Cancer Ther. 2014 Mar;13(3):752-62. doi: 10.1158/1535-7163.MCT-13-0651. Epub 2013 Dec 19.

19.

Oncolytic virus therapies.

Buonaguro FM, Tornesello ML, Izzo F, Buonaguro L.

Pharm Pat Anal. 2012 Nov;1(5):621-7. doi: 10.4155/ppa.12.65. Review.

PMID:
24236929
20.

VLPs and particle strategies for cancer vaccines.

Ungaro F, Conte C, Quaglia F, Tornesello ML, Buonaguro FM, Buonaguro L.

Expert Rev Vaccines. 2013 Oct;12(10):1173-93. doi: 10.1586/14760584.2013.836909. Review.

PMID:
24124878
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk